SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027814
Filing Date
2016-11-07
Accepted
2016-11-07 07:46:39
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thld-10q_20160930.htm 10-Q 1523648
2 EX-3.2 thld-ex32_171.htm EX-3.2 93987
3 EX-31.1 thld-ex311_9.htm EX-31.1 15564
4 EX-31.2 thld-ex312_8.htm EX-31.2 15588
5 EX-32.1 thld-ex321_7.htm EX-32.1 6194
6 EX-32.2 thld-ex322_6.htm EX-32.2 6272
  Complete submission text file 0001564590-16-027814.txt   6016922

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT thld-20160930.xml EX-101.INS 1552946
8 XBRL TAXONOMY EXTENSION SCHEMA thld-20160930.xsd EX-101.SCH 29071
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20160930_cal.xml EX-101.CAL 32049
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20160930_def.xml EX-101.DEF 104833
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20160930_lab.xml EX-101.LAB 257495
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20160930_pre.xml EX-101.PRE 213546
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 161976581
SIC: 2834 Pharmaceutical Preparations